Apollo Global Management has moved decisively past its Q2 earnings catalyst, with the stock up 7% on the week to $133.20 and analysts scrambling to revise targets upward — a post-print pattern that sets up a different kind of tension heading into the next quarter.
The analyst response to Thursday's beat has been swift and directionally clear. Barclays lifted its target to $157 from $132 on Wednesday, maintaining Overweight, while RBC raised its target to $146 from $137 the same day — the most recent moves from two firms that were actually pulling targets in mid-July when uncertainty was higher. Morgan Stanley, which nudged its target down to $164 from $165 before the print, still carries the most bullish number on the Street. The consensus mean price target now sits at $151.53, roughly 14% above the current price, with the analyst recommendation divergence factor scoring in the 97th percentile of the universe — meaning the Street's dispersion of views is unusually wide. Bulls point to record retirement services inflows of $17.2 billion and a favorable credit deployment pipeline. Bears flag the downward revision to 2025 SRE growth expectations — from around 9.5% to mid-single digits — and competitive pressure in the retail channel. The stock's forward EPS growth factor scores in the 83rd percentile, while earnings surprise history ranks in the 59th, suggesting consistent but not spectacular beats.
The options market, which spent the weeks before the print at its most bullish call-side tilt of the year, has now normalised. The put/call ratio is back to 0.78, essentially at its 20-day average of 0.77 and close to the midpoint of its 52-week range of 0.61–1.00. The extreme call skew that telegraphed the upside trade has unwound, but the ratio hasn't snapped to the defensive side either — options traders are neutral rather than positioned for follow-through. That is a notable shift from the picture described in last week's articles, where the PCR was nearly three standard deviations below its mean.
Short interest and borrow conditions remain inconsequential to the APO story. Bears hold around 4.85% of the free float — down from 5.3% six weeks ago and drifting lower steadily through the rally. Borrow availability is exceptionally loose at 820%, well above the 52-week minimum of 202%, meaning shares are abundant and the lending market creates no friction. Cost to borrow has jumped to 1.19% from 0.44% a month ago — more than doubling in a week — but in absolute terms it remains trivially low for an asset of this size. The short score ranks in just the 18th percentile, confirming that bears are not a meaningful force here. The short-side story is one of gradual retreat, not escalation.
Insider activity adds a mild cautionary note. CFO Martin Kelly sold 7,000 shares at $134.64 in mid-May, and subsidiary president John Zito sold roughly 48,600 shares across three transactions on May 27 at prices between $130 and $132. The 90-day net insider position works out to approximately 55,600 shares sold net, worth around $7.3 million. The trades are at significance scores of 3 or below and largely look like planned disposals near prior all-time levels, but they do mean that recent insider flow has been entirely one-directional at prices around where the stock now trades.
The setup heading into November's Q3 print — the next scheduled event — is that the market has already repriced the Q2 beat and analysts are updating targets in its wake. What to watch is whether the Street's wide consensus divergence narrows as more firms update their models, and whether the cost-to-borrow move — small but real — reflects any incremental demand for downside protection building quietly against a stock that has run 12% in a month.
See the live data behind this article on ORTEX.
Open APO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
